BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25677163)

  • 1. CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.
    Neumann F; Pfreundschuh M; Preuss KD; Schormann C; Zwick C; Murawski N; Kubuschok B
    Int J Cancer; 2015 Sep; 137(5):1076-84. PubMed ID: 25677163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of protein-phosphatase 2A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS/MM is due to an exchange of its regulatory subunits.
    Preuss KD; Fadle N; Regitz E; Held G; Pfreundschuh M
    Int J Cancer; 2014 Nov; 135(9):2046-53. PubMed ID: 24676687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.
    Grass S; Preuss KD; Ahlgrimm M; Fadle N; Regitz E; Pfoehler C; Murawski N; Pfreundschuh M
    Lancet Oncol; 2009 Oct; 10(10):950-6. PubMed ID: 19767238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM.
    Grass S; Preuss KD; Thome S; Weisenburger DD; Witt V; Lynch J; Zettl F; Trümper L; Fadle N; Regitz E; Lynch H; Pfreundschuh M
    Blood; 2011 Jul; 118(3):635-7. PubMed ID: 21586751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
    Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M
    Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma.
    Grass S; Iida S; Wikowicz A; Preuss KD; Inagaki A; Shimizu K; Ziepert M; Ueda R; Pfreundschuh M
    Cancer Sci; 2011 Mar; 102(3):565-8. PubMed ID: 21205072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM.
    Zwick C; Held G; Auth M; Bernal-Mizrachi L; Roback JD; Sunay S; Iida S; Kuroda Y; Sakai A; Ziepert M; Ueda R; Pfreundschuh M; Preuss KD
    Int J Cancer; 2014 Aug; 135(4):934-8. PubMed ID: 24443359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS.
    Preuss KD; Pfreundschuh M; Ahlgrimm M; Fadle N; Regitz E; Murawski N; Grass S
    Int J Cancer; 2009 Aug; 125(3):656-61. PubMed ID: 19405124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and inheritance of hyperphosphorylated paratarg-7 in patients with Waldenstrom's macroglobulinaemia in Sweden.
    Brandefors L; Lindh J; Preuss KD; Fadle N; Pfreundschuh M; Kimby E
    Acta Oncol; 2019 Jun; 58(6):824-827. PubMed ID: 30888245
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance.
    Karlsson J; Andréasson B; Kondori N; Erman E; Riesbeck K; Hogevik H; Wennerås C
    Clin Vaccine Immunol; 2011 Jun; 18(6):969-77. PubMed ID: 21508164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
    Mailankody S; Landgren O
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Miguel-Garcia A; Matutes E; Tarin F; Garcia-Talavera J; Miguel-Sosa A; Carbonell F; Catovsky D
    J Clin Pathol; 1995 Sep; 48(9):835-9. PubMed ID: 7490317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
    Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
    Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
    Paiva B; Montes MC; García-Sanz R; Ocio EM; Alonso J; de Las Heras N; Escalante F; Cuello R; de Coca AG; Galende J; Hernández J; Sierra M; Martin A; Pardal E; Bárez A; Alonso J; Suarez L; González-López TJ; Perez JJ; Orfao A; Vidríales MB; San Miguel JF
    Leukemia; 2014 Jan; 28(1):166-73. PubMed ID: 23604227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.
    Halapi E; Werner A; Wahlström J; Osterborg A; Jeddi-Tehrani M; Yi Q; Janson CH; Wigzell H; Grunewald J; Mellstedt H
    Eur J Immunol; 1997 Sep; 27(9):2245-52. PubMed ID: 9341766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
    Okagawa K; Iguchi K; Iishi Y; Kosaka M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial monoclonal gammopathy: hyper-responsive B cells in unaffected family members.
    Steingrímsdóttir H; Einarsdóttir HK; Haraldsdóttir V; Ogmundsdóttir HM
    Eur J Haematol; 2011 May; 86(5):396-404. PubMed ID: 21342269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS.
    Schmidt K; Sack U; Graf R; Winkler W; Popp O; Mertins P; Sommermann T; Kocks C; Rajewsky K
    Front Immunol; 2020; 11():602868. PubMed ID: 33343574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.